Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 study of a recombinant 2009 H1N1 swine influenza vaccine with and without Advax adjuvant
ACTRN12609000674235Phase 2Completed
- Sponsor
- Vaxine
- Start
- Jul 2009
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of recombinant 2009 H1 haemagglutinin vaccine and ADVAX in swine influenza (4 arms), sponsored by Vaxine. Primary endpoint: Seroconversion to 2009 H1N1. Started Jul 2009; status: completed.
02
Drugs
recombinant 2009 H1 haemagglutinin vaccineADVAX
03
Conditions
swine influenza
Beyond the preview
Go deeper on ACTRN12609000674235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000674235.